Prohibitin 1 regulates mtDNA release and downstream inflammatory responses.
Hao LiuHualin FanPengcheng HeHaixia ZhuangXiao LiuMeiting ChenWenwei ZhongYi ZhangCien ZhenYanling LiHuilin JiangTian MengYiming XuGuojun ZhaoDu FengPublished in: The EMBO journal (2022)
Exposure of mitochondrial DNA (mtDNA) to the cytosol activates innate immune responses. But the mechanisms by which mtDNA crosses the inner mitochondrial membrane are unknown. Here, we found that the inner mitochondrial membrane protein prohibitin 1 (PHB1) plays a critical role in mtDNA release by regulating permeability across the mitochondrial inner membrane. Loss of PHB1 results in alterations in mitochondrial integrity and function. PHB1-deficient macrophages, serum from myeloid-specific PHB1 KO (Phb1MyeKO) mice, and peripheral blood mononuclear cells from neonatal sepsis patients show increased interleukin-1β (IL-1β) levels. PHB1 KO mice are also intolerant of lipopolysaccharide shock. Phb1-depleted macrophages show increased cytoplasmic release of mtDNA and inflammatory responses. This process is suppressed by cyclosporine A and VBIT-4, which inhibit the mitochondrial permeability transition pore (mPTP) and VDAC oligomerization. Inflammatory stresses downregulate PHB1 expression levels in macrophages. Under normal physiological conditions, the inner mitochondrial membrane proteins, AFG3L2 and SPG7, are tethered to PHB1 to inhibit mPTP opening. Downregulation of PHB1 results in enhanced interaction between AFG3L2 and SPG7, mPTP opening, mtDNA release, and downstream inflammatory responses.
Keyphrases
- mitochondrial dna
- copy number
- oxidative stress
- immune response
- end stage renal disease
- acute kidney injury
- ejection fraction
- type diabetes
- toll like receptor
- signaling pathway
- intensive care unit
- genome wide
- acute myeloid leukemia
- dna methylation
- metabolic syndrome
- high fat diet induced
- patient reported outcomes
- insulin resistance
- lps induced
- septic shock